Uncategorized
Majority of adverse events in clinical trials remain unpublished
A lower number and smaller range of adverse events were reported in published studies compared with those unpublished, according to data published in PLoS Medicine.“We identified serious concerns about the substantial amount of unpublished adverse events data that may be difficult to access or ‘hidden’ from health care workers and members of the public,” Su Golder, PhD, in the Department of Health Sciences at the University of York in the United Kingdom, and colleagues wrote. “Incomplete reporting of adverse events within published studies was a consistent finding across all the (Read more...)